No significant difference in OS was observed when comparing ‘AML with KMT2A::MLLT3’ and ‘AML with KMT2A rearrangement other than KMT2A::MLLT3’ (Fig. 2F, Supplementary Table 4). The gene discussed is MLLT3; the disease is acute myeloid leukemia.